Overview Fundamentals API Earnings EOD API Sample Code Pricing

IMMUPHARMA PLC LS-01 (25I F) stock market data APIs

€0.017 0.01(100%) as of October 29, 2024
Price chart is built with Anychart

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the P140 (Lupuzor), a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140 which is in Phase II for chronic inflammatory demyelinating polyneuropathy, a progressive inflammatory condition of the nerves; and P140 in other indications for asthma, gout, periodontitis, and IBD. Its pre-clinical products include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations for serious and life-threatening fungal infections, such as aspergillosis; and BioCin, a vancomycin based treatment for anti-infection treatment. It has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of 1P40 platform; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

IMMUPHARMA PLC LS-01 Financial Data Overview

0.01
0.017
-
0.017
0.01
0.0002-0.04
9 153 K
416 M
-69 959
1.534
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '25I',
Type: 'Common Stock',
Name: 'IMMUPHARMA PLC LS-01',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'GB0033711010',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

IMMUPHARMA PLC LS-01 Fundamental Data is available in our Financial Data APIs

  • Net Revenue -69 959
  • EBITDA -2 558 742
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get IMMUPHARMA PLC LS-01 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get IMMUPHARMA PLC LS-01 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com